Ph-Like Acute Lymphoblastic Leukemia: Clinical Trials

1 trial for Ph-Like Acute Lymphoblastic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow Ph-Like Acute Lymphoblastic Leukemia: new trials by email Literature Review of Ph-Like Acute Lymphoblastic Leukemia trials Research Report on Ph-Like Acute Lymphoblastic Leukemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
Cyclophosphamide, Cytarabine, Daunorubicin Hydrochloride - B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia
Phase 1Active not recruitingCity of Hope Medical Center242022-03-172026-05-28

Narrower conditions

Burkitt Lymphoma (1)

Broader conditions

DNA Virus Infections (1)  ·  Epstein-Barr Virus Infections (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Tumor Virus Infections (1)

Interventions

Cyclophosphamide (1)  ·  Cytarabine (1)  ·  Daunorubicin (1)  ·  Mercaptopurine (1)  ·  Methotrexate (1)  ·  Prednisone (1)  ·  Vincristine (1)  ·  azathiopurine (1)  ·  deltacortene (1)  ·  merphos (1)  ·  pegaspargase (1)  ·  prednylidene (1)  ·  venetoclax (1)

Sponsors

City of Hope Medical Center (1)

Countries

United States (1)

Top investigators

Ibrahim T Aldoss (1)

NIH funding

P30CA033572 (1)